DYNAMICS OF SST2 AND NT-PROBNP IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS BASED ON COMBINED THERAPY WITH EPLERENONE AND TRIMETASIDINE ADDITION

被引:0
|
作者
Bilovol, O. M. [1 ]
Kniazkova, I. I. [1 ]
Kirienko, O. M. [1 ]
Kuzminova, N. V. [2 ]
Sushetska, A. S. [1 ]
Starenkiy, V. P. [1 ]
Abramova, L. P. [1 ]
机构
[1] Kharkiv Natl Med Univ, Kharkiv, Ukraine
[2] Natl Pirogov Mem Med Univ, Vinnytsya, Ukraine
来源
WORLD OF MEDICINE AND BIOLOGY | 2023年 / 83卷 / 01期
关键词
soluble growth-stimulatingreceptor expressed by gene 2; N-terminal fragment of brain natriuretic propeptide; diastolic function; arterial hypertension; type 2 diabetes mellitus; eplerenone; trimetazidine; SOCIETY;
D O I
10.26724/2079-8334-2023-1-83-21-25
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of our study was to investigate the effect of complex therapy with the addition of eplerenone and trimetazidine on the state of left ventricular diastolic function, as well as levels of soluble growth-stimulatingreceptor expressed by gene 2 and N-terminal fragment of brain natriuretic propeptide in patients with arterial hypertension with type 2 diabetes mellitus. After registration baseline data were recorded, 42 patients (group 1) were prescribed baseline therapy and 38 patients (group 2) were prescribed eplerenone 25-50 mg once daily and trimetazidine 80 mg once daily in addition to antihypertensive therapy for 3 months. The control group consisted of 20 practically healthy individuals. After the treatment, a significant decrease in the level of soluble growth-stimulatingreceptor expressed by gene 2 in the blood of patients in both groups was found, but in group 2 this indicator did not differ from the control group, while in group 1 it remained significantly higher than in healthy individuals. At the same time, the level of N-terminal fragment of brain natriuretic propeptide significantly decreased by 1.3 times and 1.6 times in groups 1 and 2, respectively, but remained significantly higher than in the control group. A significant decrease E/e`mean was determined in both groups of patients, but in group 2 by 8.9 % less than in group 2 and a decrease in the geometric parameters of the left atrium, more pronounced in group 2. Thus, the addition of eplerenone and trimetazidine to the complex therapy of patients with arterial hypertension and type 2 diabetes mellitus during 3 months improved diastolic function, and also had a positive effect on the biomarker of myocardial stress and fibrosis soluble growth-stimulatingreceptor expressed by gene 2 level and myocardial dysfunction N-terminal fragment of brain natriuretic propeptide concentration in serum
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [41] DURATION OF DIABETES MELLITUS IS ASSOCIATED WITH INCREASED ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Starostina, E.
    Troitskaya, E.
    Kobalava, Z.
    JOURNAL OF HYPERTENSION, 2017, 35 : E39 - E40
  • [42] Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
    Schmitt, Volker H.
    Prochaska, Juergen H.
    Foell, Annegret S.
    Schulz, Andreas
    Keller, Karsten
    Hahad, Omar
    Koeck, Thomas
    Troebs, Sven-Oliver
    Rapp, Steffen
    Beutel, Manfred
    Pfeiffer, Norbert
    Strauch, Konstantin
    Lackner, Karl J.
    Muenzel, Thomas
    Wild, Philipp S.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
    Volker H. Schmitt
    Jürgen H. Prochaska
    Annegret S. Föll
    Andreas Schulz
    Karsten Keller
    Omar Hahad
    Thomas Koeck
    Sven-Oliver Tröbs
    Steffen Rapp
    Manfred Beutel
    Norbert Pfeiffer
    Konstantin Strauch
    Karl J. Lackner
    Thomas Münzel
    Philipp S. Wild
    Scientific Reports, 11
  • [44] Galectin-3 for prediction of cardiac function and comparison to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
    Schmitt, Volker H.
    Prochaska, Juergen H.
    Foell, Annegret S.
    Schulz, Andreas
    Keller, Karsten
    Hahad, Omar
    Koeck, Thomas
    Troebs, Sven-Oliver
    Leuschner, Anja
    Arnold, Natalie
    Rapp, Steffen
    Zeller, Tanja
    Beutel, Manfred
    Pfeiffer, Norbert
    Strauch, Konstantin
    Lackner, Karl J.
    Muenzel, Thomas
    Wild, Philipp S.
    INTERNIST, 2021, 62 (SUPPL 2): : 173 - 173
  • [45] PREVALENCE OF ATHEROSCLEROSIS AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Starostina, E.
    Troitskaya, E.
    Kotovskaya, Y.
    Kobalava, Z.
    JOURNAL OF HYPERTENSION, 2017, 35 : E149 - E149
  • [46] MARKERS OF ATHEROSCLEROSIS AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Starostina, Ekaterina
    Kotovskaya, Yulia
    Kobalava, Zhanna
    JOURNAL OF HYPERTENSION, 2016, 34 : E110 - E110
  • [47] PREVALENCE OF ATHEROSCLEROSIS AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Troitskaya, E.
    Starostina, E.
    Kobalava, Z.
    JOURNAL OF HYPERTENSION, 2017, 35 : E148 - E148
  • [48] Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy
    Kanazirev, B. Branimir
    Dinkov, A.
    Hristozov, K.
    Marinova, E.
    Zlateva, V.
    Boyadjieva, M.
    Bocheva, Y.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 407 - 407
  • [49] Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study
    Landolfo, Matteo
    Spannella, Francesco
    Giulietti, Federico
    Ortensi, Beatrice
    Stella, Lucia
    Carlucci, Maria A.
    Galeazzi, Roberta
    Turchi, Federica
    Luconi, Maria P.
    Zampa, Roberto
    Cecchi, Sofia
    Tortato, Elena
    Petrelli, Massimiliano
    Sarzani, Riccardo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [50] The effect of statin therapy on oxidative stress indices in patients with arterial hypertension and type 2 diabetes mellitus
    Nemtsova, V. D.
    ZAPOROZHYE MEDICAL JOURNAL, 2018, (01) : 26 - 30